NeuroPace, Inc. (NPCE) vs SS Innovations International, Inc. (SSII)

NeuroPace, Inc. and SS Innovations International, Inc. are both Medical Devices companies. NeuroPace, Inc. is the larger, with a market value of $435.6M against $380.9M — 1.1× the size. SS Innovations International, Inc. grew revenue faster over the last twelve months: 89.7% against 11.6%. NeuroPace, Inc. has the higher net margin (−19.3% vs −23.7%) and the lower return on invested capital (−44.6% vs −11.3%). Across the 17 metrics below, SS Innovations International, Inc. leads on 9 and NeuroPace, Inc. on 8.

Valuation

Metric NPCE SSII Medical Devices median
P/E n/m n/m 25.58
P/S 4.35 7.26 2.54
P/B 36.22 7.12 2.48
Price to free cash flow n/m n/m 28.81
EV/EBITDA n/m n/m 11.51
EV/Sales 4.47 7.11 2.72
Earnings yield (4.52%) (3.16%) (12.82%)
Free cash flow yield (2.70%) (4.79%) (8.18%)

Profitability

Metric NPCE SSII Medical Devices median
Gross margin 81.57% 47.65% 57.76%
Operating margin (13.87%) (15.80%) (15.07%)
Net margin (19.34%) (23.73%) (14.45%)
Free cash flow margin (11.75%) (34.76%) (3.88%)
Return on equity (122.05%) (26.06%) (10.35%)
Return on assets (18.82%) (14.89%) (17.26%)
Return on invested capital (44.64%) (11.31%) (5.27%)

Growth

Metric NPCE SSII Medical Devices median
Revenue growth (TTM) 11.59% 89.71% 10.41%
EPS growth (last fiscal year) 29.03% 43.24% 28.17%
Revenue growth, 5-year CAGR 19.44% — 15.74%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NPCE SSII Medical Devices median
Debt to equity 4.97 0.27 0.04
Current ratio 4.94 2.24 2.74
Net debt to EBITDA 0.15 (0.32) 0.54

Dividend

Metric NPCE SSII Medical Devices median
Dividend yield — — 1.02%
Payout ratio — — 0.37

Size

Metric NPCE SSII Medical Devices median
Market cap 435.58m 380.91m 239.53m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack